Ledger.Open graph →
SEC Form D · filed February 7, 2024

Clearmind Medicine Inc

Offering
$2.4M
Sold
$2.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
VANCOUVER, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Asaf Itzhaik · Vancouver, British Columbia, CanadaDirectorDr. Adi Zuloff-Shani · Vancouver, British Columbia, CanadaExecAlan Rootenberg · Vancouver, British Columbia, CanadaExecYehonatan Shachar · Vancouver, British Columbia, CanadaDirectorAmitay Weiss · Bnei Brak, L3DirectorOz Adler · Givatayim, L3DirectorProf. Mark Haden · Vancouver, British Columbia, CanadaExecYehonatan Shachar · Vancouver, British Columbia, CanadaDirectorAsaf Itzhaik · Vancouver, British Columbia, CanadaDirectorDr. Adi Zuloff-Shani · Vancouver, British Columbia, CanadaExecAmitay Weiss · Bnei Brak, L3DirectorAlan Rootenberg · Thornhill, Ontario, CanadaExecOz Adler · Givatayim, L3DirectorProf. Mark Haden · Vancouver, British Columbia, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗